专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

RU2728576C1 ВОЗДУШНЫЙ ТЕПЛОВОЙ НАСОС 未知
公开(公告)号：RU2728576C1
公开(公告)日：2020-07-30
申请号：RU2019133627
申请日：2018-03-30
申请人： ZHANG JIN
发明人： ZHANG JIN
IPC分类号： F01K21/00 , F22B3/06
摘要： Изобретениеотноситсяк преобразованиюэнергии, аименнок воздушнымтепловымнасосам. Вращающийсявалнасосанеподвижноустановленнавыходномконцевращающегосяблока. Вращающийсявалимеетпоменьшеймереодинвыступ. Приводнойпоршенькаждогоузлапреобразованияустановленс возможностьюскольженияв воздушнойполости. Приводнойпоршеньделитвоздушнуюполостьнапервуюполостьи вторуюполость. Шатунустановленвовторойполостии неподвижносоединенс приводнымпоршнем. Дваконцаприводногорычагасоединеныс возможностьювращенияс шатуноми указаннымвыступомсоответственно. Перваяполостьснабженаотверстиемдлянаполнениявоздухом. Нескольконагревательныхтрубокоднимконцомсоединеныс первойполостью, адругимконцомвставленыв корпуснасоса. Корпуснасосаимеетгерметичноеисполнение, внутрикорпусахранитсявода, корпусснабженвыпускнымотверстием, котороеподключаетсяк каждойточкепотреблениячерезтрубопровод. Посколькунастоящееизобретениеиспользуетвоздухв качествеисточникаэнергиидлянагревания, тоононеимеетограниченийпоустановкеи являетсябезопасными энергосберегающимприэксплуатации. 6 з.п. ф-лы, 2 ил.

2. 发明专利

CA2906871A1 LUMINESCENT RESONANCE ENERGY TRANSFER SENSORS FOR NON-INVASIVELY AND CONTINUOUSLY MONITORING GLUCOSE FOR DIABETES 未知
公开(公告)号：CA2906871A1
公开(公告)日：2016-03-26
申请号：CA2906871
申请日：2015-09-28
申请人： ZHANG JIN
发明人： ZHANG JIN , WANG XIANBIN
IPC分类号： A61B5/145 , A61B5/1455 , A61B5/1486 , B82Y15/00 , C12M1/34 , C12Q1/54 , G01N21/76 , G01N33/483 , G02C11/00
摘要： The present disclosure discloses a non-invasive wireless glucose level monitoring device. The device is fitted into a contact lens and can analyze glucose levels in tear fluid. The results of the analysis can be continuously transmitted to a nearby receiver and uploaded to a computer, mobile device or server.

3. 发明专利

AU2011316879A1 Medical device 未知
公开(公告)号：AU2011316879A1
公开(公告)日：2013-05-23
申请号：AU2011316879
申请日：2011-10-21
申请人： PEARCE RICHARD H , SCHNEIDER JOHN B , ZHANG JIN
发明人： SCHNEIDER JOHN B , PEARCE RICHARD H , ZHANG JIN
IPC分类号： G06F19/00 , G16H10/60
摘要： A modular medical device includes a core module housing. The core module housing includes a treatment module interface configured to couple to any one of a plurality of treatment modules, and each of the plurality of treatment modules includes a treatment assembly configured to apply a medical treatment. The core housing module contains one or more processing devices coupled to the treatment module interface and configured to determine which particular treatment module, from the plurality of treatment modules, is coupled to the treatment module interface. The one or more processing devices are configured to select, based on the determination, a set of control instructions for the particular treatment module from a plurality of control instructions, and control the particular treatment module using the selected control instructions such that the treatment assembly of the particular treatment module applies the medical treatment for which the treatment assembly is configured.

4. 发明专利

CA2815474A1 MEDICAL DEVICE 未知
公开(公告)号：CA2815474A1
公开(公告)日：2012-04-26
申请号：CA2815474
申请日：2011-10-21
申请人： TANIS KEVIN J , ZHANG JIN
发明人： TANIS KEVIN J , ZHANG JIN
IPC分类号： G06F19/00 , G16H10/60
摘要： A medical device includes a treatment module configured to apply a medical treatment and one or more storage devices storing a device identifier that identifies the medical device. The medical device also includes one or more processing devices configured to control the treatment module to apply a medical treatment, collect compliance information that reflects a patient's compliance with a treatment regimen, access the device identifier from the one or more storage devices, and send the collected compliance information with the accessed device identifier to a server system. The server system is configured to receive the compliance information and the device identifier, determine a patient identifier based on the device identifier, store the compliance information in association with the determined patient identifier, and provide access to the compliance information in response to an inquiry.

5. 发明专利

HK1118214A1 A TREATMENT SOLUTION AND METHOD FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS 未知
公开(公告)号：HK1118214A1
公开(公告)日：2009-02-06
申请号：HK08109475
申请日：2008-08-26
申请人： ZHANG JIN JUN
发明人： ZHANG JIN JUN
IPC分类号： A61K20060101 , A61K9/00 , A61K31/045 , A61K31/185 , A61K31/198 , A61K31/70 , A61P20060101
摘要： A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution may also be applied to the intraocular lens prior to surgery. The treatment solution comprises an ion transport mechanism interference agent, which either alone or in combination with other treatment agents such as an osmotic stress agent to establish a suitable pH, selectively induces detachment and/or death of lens epithelial cells such that posterior capsular opacification is prevented. While the ion transport mechanism interference agent is capable of interfering with the cellular mechanisms and cell ion distribution of a broad range of cells, a concentration of agent is selected such that the treatment solution interferes selectively with the cellular mechanisms of lens epithelial cells while leaving other ocular cells substantially unharmed. The treatment solution selectively induces cellular death and/or detachment of lens epithelial cells while other ocular cells and tissue substantially unharmed and without lengthy preoperative pretreatment.

6. 发明专利

HK1085130A1 A TREATMENT SOLUTION AND USE FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS 未知
公开(公告)号：HK1085130A1
公开(公告)日：2006-08-18
申请号：HK06105311
申请日：2006-05-04
申请人： ZHANG JIN JUN
发明人： ZHANG JIN JUN
IPC分类号： A61K20060101 , A61K9/00 , A61K31/045 , A61K31/185 , A61K31/198 , A61K31/70
摘要： A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution comprises an ion transport mechanism interference agent, which either alone or in combination with other treatment agents such as an osmotic stress agent and an agent to establish a suitable pH, selectively induces detachment and/or death of lens epithelial cells such that posterior capsular opacification is prevented. While the ion transport mechanism interference agent is capable of interfering with the cellular mechanisms and cell ion distribution of a broad range of cells, a concentration of agent is selected such that the treatment solution interferes selectively with the cellular mechanisms of lens epithelial cells while leaving other ocular cells substantially unharmed. The treatment solution selectively induces cellular death and/or detachment of lens epithelial cells while other ocular cells and tissue remain substantially unharmed and without lengthy preoperative pre-treatment.

7. 发明专利

CA2592069A1 A TREATMENT SOLUTION AND METHOD FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS 未知
公开(公告)号：CA2592069A1
公开(公告)日：2006-06-22
申请号：CA2592069
申请日：2005-12-19
申请人： ZHANG JIN JUN
发明人： ZHANG JIN JUN
IPC分类号： A61K9/08 , A61K9/00 , A61K31/045 , A61K31/185 , A61K31/198 , A61K31/549 , A61K31/70 , A61P27/02
摘要： A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution may also be applied to the intraocular lens prior to surgery. The treatment solution comprises an ion transport mechanism interference agent, which either alone or in combination with other treatment agents such as an osmotic stress agent to establish a suitable pH, selectively induces detachment and/or death of lens epithelial cells such that posterior capsular opacification is prevented. While the ion transport mechanism interference agent is capable of interfering with the cellular mechanisms and cell ion distribution of a broad range of cells, a concentration of agent is selected such that the treatment solution interferes selectively with the cellular mechanisms of lens epithelial cells while leaving other ocular cells substantially unharmed. The treatment solution selectively induces cellular death and/or detachment of lens epithelial cells while other ocular cells and tissue substantially unharmed and without lengthy preoperative pretreatment.

8. 发明专利

CA2683467C CONTACT LENS INTEGRATED WITH A BIOSENSOR FOR DETECTION OF GLUCOSE AND OTHER COMPONENTS IN TEARS 未知
公开(公告)号：CA2683467C
公开(公告)日：2016-01-26
申请号：CA2683467
申请日：2009-10-26
申请人： ZHANG JIN , HODGE WILLIAM GERALD
发明人： ZHANG JIN , HODGE WILLIAM GERALD
IPC分类号： G02C7/04 , A61B5/00 , G02C11/00
摘要： The present invention provides contact lens with integrated biosensor for the continuous, non-invasive monitoring of physiological glucose by employing biocompatible nanostructure-laden lens materials. These contact lenses can be worn by diabetics who can colorimetrically see changes in their contact lens color or other fluorescence-based properties, giving an indication of tear and blood glucose levels. This invention for the glucose biosensor based on the new disposal contact lens provides a safe, convenient and non-expensive glucose sensing device. The sensing device disclosed herein provides an efficient and noninvasive solution for monitoring blood glucose.

9. 发明专利

AU2011316599A1 Medical device 未知
公开(公告)号：AU2011316599A1
公开(公告)日：2013-05-02
申请号：AU2011316599
申请日：2011-10-12
申请人： TANIS KEVIN , MEYERS KELLY , ARRINGTON DEBRA , ZHANG JIN
发明人： TANIS KEVIN J , ZHANG JIN , ARRINGTON DEBRA ANN , MEYERS KELLY ANN
IPC分类号： A61B19/00 , A61N7/00 , G16H10/60
摘要： A medical device includes a treatment module configured to apply a treatment to a patient. The medical device includes an interface configured to operatively connect to a removable storage device storing authorization data that identifies a level of treatment authorization. The medical device includes a processing device configured to perform operations in response to receiving user input indicating a treatment should be initiated. The operations include determining whether the removable storage device is valid for use with the medical device. If the removable storage device is determined to be valid, the authorization data is accessed. The processing device determines whether the treatment is authorized based on the accessed authorization data. If the treatment is determined to be authorized, the treatment module is controlled to apply the treatment. If the treatment is determined to not be authorized, the treatment module is controlled such that the treatment is not applied.

10. 发明专利

CA2592069C A TREATMENT SOLUTION AND METHOD FOR PREVENTING POSTERIOR CAPSULAR OPACIFICATION BY SELECTIVELY INDUCING DETACHMENT AND/OR DEATH OF LENS EPITHELIAL CELLS 未知
公开(公告)号：CA2592069C
公开(公告)日：2012-05-22
申请号：CA2592069
申请日：2005-12-19
申请人： ZHANG JIN JUN
发明人： ZHANG JIN JUN
IPC分类号： A61K9/08 , A61K9/00 , A61K31/045 , A61K31/185 , A61K31/198 , A61K31/549 , A61K31/70 , A61P27/02
摘要： A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution may also be applied to the intraocular lens prior to surgery. The treatment solution comprises an ion transport mechanism interference agent, which either alone or in combination with other treatment agents such as an osmotic stress agent to establish a suitable pH, selectively induces detachment and/or death of lens epithelial cells such that posterior capsular opacification is prevented. While the ion transport mechanism interference agent is capable of interfering with the cellular mechanisms and cell ion distribution of a broad range of cells, a concentration of agent is selected such that the treatment solution interferes selectively with the cellular mechanisms of lens epithelial cells while leaving other ocular cells substantially unharmed. The treatment solution selectively induces cellular death and/or detachment of lens epithelial cells while other ocular cells and tissue substantially unharmed and without lengthy preoperative pre-treatment.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式